Published in Ann Intern Med on April 15, 1990
Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother (1991) 2.13
Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges. Antimicrob Agents Chemother (1993) 1.79
Pathogenesis and pathophysiology of bacterial meningitis. Clin Microbiol Rev (1993) 1.45
Cefotaxime breakpoint for Streptococcus pneumoniae. Antimicrob Agents Chemother (1993) 1.15
High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins. Antimicrob Agents Chemother (1996) 1.11
Concentrations of ceftriaxone in cerebrospinal fluid of children with meningitis receiving dexamethasone therapy. Antimicrob Agents Chemother (1994) 0.99
Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies. Antimicrob Agents Chemother (1996) 0.93
Kinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patients. Antimicrob Agents Chemother (1997) 0.90
Therapy of experimental meningitis due to Salmonella enteritidis. Antimicrob Agents Chemother (1992) 0.87
Management of cerebral infection. J Neurol Neurosurg Psychiatry (1993) 0.86
Effects of transforming growth factor-beta on murine astrocyte glutamine synthetase activity. Implications in neuronal injury. J Clin Invest (1992) 0.84
Transforming growth factor beta 2 inhibits cerebrovascular changes and brain edema formation in the tumor necrosis factor alpha-independent early phase of experimental pneumococcal meningitis. J Exp Med (1992) 0.84
Morphological study in the early stages of complement C5a fragment-induced experimental meningitis: activation of macrophages and astrocytes. Acta Neuropathol (1995) 0.82
Cerebral blood flow velocity monitoring in pyogenic meningitis. Arch Dis Child (1993) 0.76
Role of glucocorticosteroids in the treatment of infectious diseases. Eur J Clin Microbiol Infect Dis (1993) 0.76
Bacterial meningitis in emergency departments. West J Med (1991) 0.75
Meta-analysis of studies comparing adjuvant dexamethasone to glycerol to improve clinical outcome of bacterial meningitis. J Res Med Sci (2016) 0.75
Unanswered questions in central nervous system infection. Can J Infect Dis (1992) 0.75
Neurology. Postgrad Med J (1991) 0.75
Platelet-activating factor augments meningeal inflammation elicited by Haemophilus influenzae lipooligosaccharide in an animal model of meningitis. Infect Immun (1994) 0.75
Dexamethasone for meningitis. Ann Intern Med (1990) 0.75
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med (1994) 9.11
Acute bacterial meningitis. Lancet (1996) 6.47
Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin. J Clin Invest (1978) 4.38
Treatment of bacterial meningitis. N Engl J Med (1997) 3.07
Combination antibiotic therapy of bacterial endocarditis. Ann Intern Med (1980) 3.03
Infectious etiologies of rhabdomyolysis: three case reports and review. Clin Infect Dis (1996) 2.80
Bacterial meningitis: pathogenesis, pathophysiology, and progress. N Engl J Med (1992) 2.40
Recent development of rigors during infusion of urokinase: is it related to an endotoxin? J Vasc Interv Radiol (1994) 2.01
In vitro binding of Candida albicans yeast cells to human fibronectin. Can J Microbiol (1984) 1.98
Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits. J Clin Invest (1983) 1.93
Comparative pharmacology of cefaclor and cephalexin. Antimicrob Agents Chemother (1977) 1.86
Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J Clin Invest (1991) 1.77
The postantibiotic effect in the treatment of experimental meningitis caused by Streptococcus pneumoniae in rabbits. J Infect Dis (1984) 1.67
Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency. Antimicrob Agents Chemother (1981) 1.66
Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone. J Clin Invest (1980) 1.64
Morphologic alterations of the blood-brain barrier with experimental meningitis in the rat. Temporal sequence and role of encapsulation. J Clin Invest (1986) 1.63
Response to therapy in an experimental rabbit model of meningitis due to Listeria monocytogenes. J Infect Dis (1979) 1.57
Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists. Br J Pharmacol (2001) 1.53
Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects. Antimicrob Agents Chemother (1981) 1.51
In vitro susceptibility studies with cefaclor and cephalexin. Antimicrob Agents Chemother (1977) 1.51
Microbial adhesion to fibronectin in vitro correlates with production of endocarditis in rabbits. Proc Soc Exp Biol Med (1985) 1.50
Intermittent or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivo. Rev Infect Dis (1981) 1.49
Yeast adhesion in the pathogenesis of endocarditis due to Candida albicans: studies with adherence-negative mutants. J Infect Dis (1985) 1.48
Predicting pass rates on the American Board of Internal Medicine certifying examination. J Gen Intern Med (1998) 1.47
Haemophilus influenzae lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat. J Clin Invest (1988) 1.47
Pathogenesis and pathophysiology of bacterial meningitis. Clin Microbiol Rev (1993) 1.45
The use of corticosteroids in the management of bacterial meningitis in adults. J Antimicrob Chemother (1996) 1.43
Issues in the management of bacterial meningitis. Am Fam Physician (1997) 1.40
Influence of preformed antibody on experimental Streptococcus sanguis endocarditis. Infect Immun (1979) 1.36
Postsplenectomy sepsis with DF-2: report of a case with isolation of the organism from the patient's dog. Ann Intern Med (1980) 1.34
Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction. Antimicrob Agents Chemother (1980) 1.34
Infections of the central nervous system. Adv Intern Med (1998) 1.33
The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s. Clin Infect Dis (1997) 1.33
Bacterial adhesion in the pathogenesis of infective endocarditis. Effect of subinhibitory antibiotic concentrations on streptococcal adhesion in vitro and the development of endocarditis in rabbits. J Clin Invest (1981) 1.31
Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipients. Transpl Infect Dis (2009) 1.29
Evaluation of aztreonam in experimental bacterial meningitis and cerebritis. Antimicrob Agents Chemother (1983) 1.26
Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction. Antimicrob Agents Chemother (1983) 1.23
Haemophilus influenzae outer membrane vesicle-induced blood-brain barrier permeability during experimental meningitis. Infect Immun (1989) 1.22
Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis. J Antimicrob Chemother (1983) 1.20
Comparison of netilmicin with gentamicin in the therapy of experimental Escherichia coli meningitis. Antimicrob Agents Chemother (1978) 1.18
Pneumonia treated with imipenem/cilastatin. Am J Med (1985) 1.18
Comparison of cefoperazone with penicillin, ampicillin, gentamicin, and chloramphenicol in the therapy of experimental meningitis. Antimicrob Agents Chemother (1982) 1.18
Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram. J Infect Dis (1999) 1.18
Strategies for stemming the tide of antimicrobial resistance. JAMA (1998) 1.15
Problems in salmonellosis: rationale for clinical trials with newer beta-lactam agents and quinolones. Rev Infect Dis (1986) 1.14
Etiology and mortality of bacterial meningitis in northeastern Brazil. Rev Infect Dis (1990) 1.13
The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. J Allergy Clin Immunol (1992) 1.12
Diagnostic value of echocardiography in suspected endocarditis. An evaluation based on the pretest probability of disease. Circulation (1996) 1.11
Clearance of bacteria from cerebrospinal fluid to blood in experimental meningitis. Infect Immun (1979) 1.10
Brain abscess. Semin Neurol (2000) 1.09
Effect of methylprednisolone on entry of ampicillin and gentamicin into cerebrospinal fluid in experimental pneumococcal and Escherichia coli meningitis. Antimicrob Agents Chemother (1983) 1.07
Mechanisms of brain injury in bacterial meningitis: workshop summary. Clin Infect Dis (1994) 1.04
Rifampin in experimental endocarditis due to Staphylococcus aureus in rabbits. Rev Infect Dis (1983) 1.03
Enzyme-linked immunosorbent assay for detection of Streptococcus pneumoniae antigen. J Clin Microbiol (1979) 1.01
Enigmatic enterococcal endocarditis. Ann Intern Med (1984) 1.01
Role of fibronectin in the pathogenesis of candidal infections. Rev Infect Dis (1988) 1.01
Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium. Arch Intern Med (1997) 1.00
Comparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis. Antimicrob Agents Chemother (1985) 0.99
Oral ciprofloxacin therapy for gram-negative bacillary osteomyelitis. Am J Med (1987) 0.98
Co-trimoxazole versus nafcillin in the therapy of experimental meningitis due to Staphylococcus aureus. J Antimicrob Chemother (1987) 0.94
Rigid nasal endoscopy versus sinus puncture and aspiration for microbiologic documentation of acute bacterial maxillary sinusitis. Clin Infect Dis (2001) 0.94
Role of cerebrospinal fluid pleocytosis and Haemophilus influenzae type b capsule on blood brain barrier permeability during experimental meningitis in the rat. J Clin Invest (1988) 0.94
Pathophysiological correlates in bacterial meningitis. J Infect (1981) 0.93
A pseudo-outbreak of nosocomial infections associated with the introduction of an antibiotic management programme. J Hosp Infect (2003) 0.93
Comparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitis. Antimicrob Agents Chemother (1985) 0.92
Evaluation of mezlocillin in discriminative animal models of infection. J Antimicrob Chemother (1982) 0.92
Mecillinam-ampicillin synergism in experimental Enterobacteriaceae meningitis. Antimicrob Agents Chemother (1979) 0.91
Clindamycin therapy of experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother (1982) 0.90
Evaluation of azlocillin in vitro and in discriminative animal models of infection. J Antimicrob Chemother (1983) 0.89
Influence of preformed antibody on the pathogenesis of experimental Candida albicans endocarditis. Infect Immun (1983) 0.89
Staphylococcus aureus ventriculitis treated with single-dose intraventricular vancomycin or daptomycin (LY146032): bacterial and antibiotic kinetics in hydrocephalic rabbits. Antimicrob Agents Chemother (1990) 0.89
New perspectives on bacterial meningitis. Clin Infect Dis (1993) 0.88
Case report: venous thromboembolism in AIDS. Am J Med Sci (1992) 0.88
Potential role of nitric oxide in the pathophysiology of experimental bacterial meningitis in rats. Infect Immun (1995) 0.88
Theoretical and practical considerations of antibiotic therapy for bacterial meningitis. Pediatr Infect Dis (1985) 0.88
Ciprofloxacin in the treatment of Staphylococcus aureus osteomyelitis. A review. Diagn Microbiol Infect Dis (1990) 0.88
Therapy of experimental meningitis due to Salmonella enteritidis. Antimicrob Agents Chemother (1992) 0.87
Moxalactam for the treatment of bacterial meningitis in children. J Infect Dis (1983) 0.87
Comparison of once-daily cephalosporin regimens for community-acquired lower respiratory tract infections in patients with chronic lung disease. Clin Ther (1989) 0.87
Rationale for optimal dosing of beta-lactam antibiotics in therapy for bacterial meningitis. Eur J Clin Microbiol (1984) 0.86
Blood-brain barrier alterations in bacterial meningitis: development of an in vitro model and observations on the effects of lipopolysaccharide. In Vitro Cell Dev Biol (1991) 0.86
Pharmacokinetics of multiple-dose cefoperazone in hemodialysis patients. Am J Nephrol (1985) 0.86
Societal costs versus savings from wild-card patent extension legislation to spur critically needed antibiotic development. Infection (2007) 0.86
Brain injury in bacterial meningitis: therapeutic implications. Curr Opin Neurol (1997) 0.86
Detection of circulating antigen in experimental Candida albicans endocarditis by an enzyme-linked immunosorbent assay. J Clin Microbiol (1980) 0.85
Comparison of cyclacillin and amoxicillin for therapy for acute maxillary sinusitis. Antimicrob Agents Chemother (1986) 0.85
Time course of hearing loss in an animal model of pneumococcal meningitis. Otolaryngol Head Neck Surg (1999) 0.84
Adjunctive therapy for bacterial meningitis: rationale for use, current status, and prospects for the future. Clin Infect Dis (1993) 0.84
Recent advances in the pathogenesis and pathophysiology of bacterial meningitis. Am J Med Sci (1986) 0.84
Pulmonary infection with capsule-deficient cryptococcus neoformans. Virchows Arch A Pathol Anat Histol (1979) 0.84
Applications of therapy in animal models to bacterial infection in human disease. Infect Dis Clin North Am (1989) 0.83
Fever in neurologic diseases. Infect Dis Clin North Am (1996) 0.83
Brain abscess. Clin Neuropharmacol (1987) 0.83
Cross-linked bispecific monoclonal antibody heteropolymers facilitate the clearance of human IgM from the circulation of squirrel monkeys. Eur J Immunol (1994) 0.83
Factors influencing the pathogenesis and prevention of infective endocarditis. Scand J Infect Dis Suppl (1982) 0.82
Experimental studies of biliary excretion of piperacillin. Ann Surg (1987) 0.82
Bacterial meningitis in the patient at risk: intrinsic risk factors and host defense mechanisms. Am J Med (1984) 0.82
Candida prosthetic arthritis: report of a case treated with fluconazole and review of the literature. Am J Med (1993) 0.82
Effects of sub-bactericidal concentrations of antibiotics in experimental models of endocarditis. J Antimicrob Chemother (1985) 0.82